DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 886 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $8,637,000 | +4.0% | 33,439 | +2.1% | 0.26% | -5.8% |
Q2 2022 | $8,307,000 | -12.5% | 32,766 | +1.3% | 0.27% | +2.2% |
Q1 2022 | $9,493,000 | -8.2% | 32,361 | +2.9% | 0.27% | -7.3% |
Q4 2021 | $10,342,000 | +7.7% | 31,434 | -0.4% | 0.29% | -0.7% |
Q3 2021 | $9,606,000 | +11.7% | 31,554 | -1.5% | 0.29% | +10.2% |
Q2 2021 | $8,597,000 | +17.9% | 32,037 | -1.1% | 0.26% | +7.3% |
Q1 2021 | $7,291,000 | +4.6% | 32,392 | +3.3% | 0.25% | -10.9% |
Q4 2020 | $6,968,000 | +7.1% | 31,367 | +3.8% | 0.28% | -5.5% |
Q3 2020 | $6,508,000 | +13.5% | 30,221 | -6.8% | 0.29% | -8.5% |
Q2 2020 | $5,733,000 | +34.2% | 32,422 | +5.0% | 0.32% | -4.2% |
Q1 2020 | $4,272,000 | -15.4% | 30,865 | -6.2% | 0.33% | +8.8% |
Q4 2019 | $5,048,000 | +0.3% | 32,892 | -5.6% | 0.31% | -7.8% |
Q3 2019 | $5,032,000 | -1.7% | 34,843 | -2.7% | 0.33% | -3.8% |
Q2 2019 | $5,119,000 | +3.1% | 35,815 | -4.8% | 0.34% | -0.3% |
Q1 2019 | $4,964,000 | +29.9% | 37,603 | +1.5% | 0.35% | +6.8% |
Q4 2018 | $3,821,000 | +0.3% | 37,053 | +5.7% | 0.32% | +11.0% |
Q3 2018 | $3,808,000 | +10.2% | 35,045 | +0.1% | 0.29% | -2.0% |
Q2 2018 | $3,455,000 | -2.9% | 35,009 | -3.7% | 0.30% | +0.3% |
Q1 2018 | $3,560,000 | +1.3% | 36,365 | -3.9% | 0.30% | +3.1% |
Q4 2017 | $3,514,000 | +3.3% | 37,854 | -4.5% | 0.29% | -2.0% |
Q3 2017 | $3,401,000 | -18.0% | 39,652 | -19.3% | 0.29% | -22.0% |
Q2 2017 | $4,146,000 | -5.0% | 49,126 | -3.7% | 0.38% | -6.9% |
Q1 2017 | $4,365,000 | +41.7% | 51,036 | +28.9% | 0.40% | +34.6% |
Q4 2016 | $3,081,000 | +26.6% | 39,582 | +27.5% | 0.30% | +19.9% |
Q3 2016 | $2,433,000 | +692.5% | 31,034 | +920.2% | 0.25% | +736.7% |
Q2 2016 | $307,000 | -19.2% | 3,042 | -24.0% | 0.03% | -28.6% |
Q1 2016 | $380,000 | +2.2% | 4,005 | 0.0% | 0.04% | +5.0% |
Q4 2015 | $372,000 | +20.8% | 4,005 | +11.0% | 0.04% | +33.3% |
Q3 2015 | $308,000 | -18.7% | 3,609 | -18.5% | 0.03% | -11.8% |
Q2 2015 | $379,000 | +3.0% | 4,430 | +2.2% | 0.03% | +6.2% |
Q1 2015 | $368,000 | -99.9% | 4,335 | 0.0% | 0.03% | +3.2% |
Q4 2014 | $371,553,000 | +114224.0% | 4,335 | +1.2% | 0.03% | +3.3% |
Q3 2014 | $325,000 | -7.9% | 4,282 | -4.6% | 0.03% | -9.1% |
Q2 2014 | $353,000 | +6.3% | 4,487 | +1.2% | 0.03% | +3.1% |
Q1 2014 | $332,000 | -0.6% | 4,432 | +2.3% | 0.03% | 0.0% |
Q4 2013 | $334,000 | +11.3% | 4,332 | 0.0% | 0.03% | -3.0% |
Q3 2013 | $300,000 | +14.9% | 4,332 | +5.2% | 0.03% | +6.5% |
Q2 2013 | $261,000 | – | 4,117 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |